Singular Genomics Sys (NASDAQ: OMIC)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-02 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.310 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Singular Genomics Sys (NASDAQ: OMIC) through any online brokerage.
Other companies in Singular Genomics Sys’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), Quanterix (NASDAQ:QTRX), ChromaDex (NASDAQ:CDXC) and SomaLogic (NASDAQ:SLGC).
The latest price target for Singular Genomics Sys (NASDAQ: OMIC) was reported by Goldman Sachs on Wednesday, May 11, 2022. The analyst firm set a price target for 9.50 expecting OMIC to rise to within 12 months (a possible 136.32% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Singular Genomics Sys (NASDAQ: OMIC) is $4.02 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Singular Genomics Sys.
Singular Genomics Sys’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for Singular Genomics Sys.
Singular Genomics Sys is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.